investor_presentation
Daseke
Loading viewer...
investor_presentation
Format: PDF investor_presentation
Quantum presents its diversified R&D portfolio spanning recreational and medical alcohol misuse treatments (unbuzzd, rekvry) and a proprietary multiple sclerosis therapeutic candidate (LUCID-21-302). The company maintains a capital-efficient model through royalty agreements and equity stakes while retaining exclusive IP rights for pharmaceutical applications and demyelinating disease treatments.
investor_presentation
62 Pages
investor_presentation
22 Pages
PolyPid
investor_presentation
Daseke
Greenbrier Companies GBX June 2023 Investor Presentation
investor_presentationinvestor_presentation
46 Pages
The Greenbrier Companies, Inc.